Thursday, February 27, 2014

Diabetes Drugs Safe


Officials of the Food and Drug Administration and the European Medication agency published their concerns about diabetes drugs on an annual joint paper. The announced the popular drugs unsafe and could cause pancreatic inflammation. The drugs that increase a hormone activity to control blood sugar, including Onglyza, Victoza, and Januvia, make millions of dollars in the market in sales. Both of the agencies have collective effort to show the link between the drugs use and their damages. A study that supported this situation was done by Dr. Peter C. Butler, from the University of California, Los Angles. Many of Dr. Butler critics claimed that his conclusion was not supported and asked for the analyses to be public. After a little tension between those asking for more research and those seeing little need for concern both the European agency and the FDA announced that there was no concern regarding the safety of the drugs. The agencies have also announced that more data will be collected and that concerns regarding pancreatic inflammation were already written in the labels of the drugs.

Diabetes’ percentage is around the world and percentage in developed countries such as the US and those in Europe are very high. McDonaldization and other social factors that caused the world to move faster, Diabetes is becoming a trend and almost a common disease in families. Regardless of the factors or causes of diabetes, its cure is one around the world. This alert of and ‘unsafe’ medicine is scary and causes the sick to feel worst. Diabetic people are dependent on the medicine and no substitutions are currently unavailable: to know that your medication can cause further and more serious illness is something that affects part of the population worldwide. Further and deeper studies should be done regarding all diabetes’ drugs available in the market.

 
http://www.nytimes.com/2014/02/27/health/us-and-european-regulators-call-popular-diabetes-drugs-safe.html?ref=health

No comments:

Post a Comment